Family Medicine · Flushing, NY
NPI
1578625737
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
13338 41st Rd, Suite Co-3
Flushing, NY, 11355
Phone (718) 359-8829
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
772 services
Medicare patients, 2024
62
Average age 76
Drug cost, 2024
$4.2M
22,252 prescriptions
Company payments, 2025
$913
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yi Ngai was code 99214 (office e&m - established), 136 times for 48 patients. In total Yi Ngai billed 772 services in 35 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 136 | 48 | $92.38 | $13K |
| 36415 Venipuncture Blood Collection | Office | 110 | 51 | $8.65 | $952 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 51 | 51 | $21.37 | $1,090 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 44 | 42 | $14.75 | $649 |
| 99497 Care Management/Coordination | Office | 44 | 44 | $75.38 | $3,317 |
| 99213 Office E&M - Established | Office | 43 | 25 | $59.31 | $2,550 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 42 | 42 | $27.85 | $1,170 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 40 | 40 | $21.44 | $857 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 40 | 40 | $144.70 | $5,788 |
| 96372 Injection Administration | Office | 38 | 13 | $10.83 | $412 |
| G0008 Administration of influenza virus vaccine | Office | 24 | 22 | $36.42 | $874 |
| 96127 Behavioral Health Services | Office | 21 | 11 | $2.96 | $62.13 |
| 90656 Vaccine Product | Office | 19 | 19 | $21.90 | $416 |
| 90471 Vaccine Administration | Office | 14 | 13 | $9.31 | $130 |
| 99441 Telephone Services | Office | 13 | 12 | $29.87 | $388 |
By year: 2022 $39K for 794 services; 2023 $41K for 744 services; 2024 $34K for 772 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 110 | 51 | $8.65 | $952 |
Medicare prescription drug claims, 2024
In 2024, the drug Yi Ngai prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,854 prescriptions and refills. In total Yi Ngai wrote 22,252 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,854 | 3,854 | 407 | $14K |
| Losartan Potassium Generic | 1,219 | 2,399 | 240 | $8,663 |
| Vascepa Icosapent Ethyl | 1,193 | 1,822 | 209 | $626K |
| Amlodipine Besylate Generic | 905 | 1,773 | 183 | $5,332 |
| Levothyroxine Sodium Generic | 649 | 1,296 | 125 | $6,177 |
| Rosuvastatin Calcium Generic | 616 | 1,171 | 123 | $4,693 |
| Raloxifene Hcl Generic | 576 | 1,057 | 110 | $11K |
| Metoprolol Succinate Generic | 424 | 800 | 90 | $3,853 |
| Clopidogrel Clopidogrel Bisulfate | 407 | 720 | 77 | $2,636 |
| Folic Acid Generic | 406 | 875 | 124 | $851 |
| Metformin Hcl Generic | 391 | 825 | 80 | $2,035 |
| Atenolol Generic | 385 | 724 | 69 | $2,246 |
| Zolpidem Tartrate Generic | 344 | 344 | 89 | $2,660 |
| Tamsulosin Hcl Generic | 340 | 599 | 70 | $2,820 |
| Farxiga Dapagliflozin Propanediol | 337 | 618 | 72 | $345K |
Brand drugs: 5,427 claims; generic drugs: 16,398 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yi Ngai $913 ($913 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $268.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $268 |
| Gilead Sciences, Inc. GILD | 12 | $199 |
| Abbvie Inc. ABBV | 5 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58.38 |
| GlaxoSmithKline, LLC. GSK | 3 | $55.49 |
| Ardelyx, Inc. ARDX | 2 | $46.03 |
| Novo Nordisk Inc NVO | 2 | $42.67 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $38.31 |
| Abbott Laboratories ABT | 2 | $37.08 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $20.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.